APA (7th ed.) Citation

Jamookeeah, C., Robinson, P., O'Reilly, K., Lundberg, J., Gisby, M., Ländin, M., . . . Trueman, D. (2016). Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden. BMC Endocrine Disorders, 16, 1. https://doi.org/10.1186/s12902-016-0104-z

Chicago Style (17th ed.) Citation

Jamookeeah, Clare, Paul Robinson, Karl O'Reilly, Johan Lundberg, Martin Gisby, Michael Ländin, Jakob Skov, and David Trueman. "Cost-effectiveness of Tolvaptan for the Treatment of Hyponatraemia Secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion in Sweden." BMC Endocrine Disorders 16 (2016): 1. https://doi.org/10.1186/s12902-016-0104-z.

MLA (9th ed.) Citation

Jamookeeah, Clare, et al. "Cost-effectiveness of Tolvaptan for the Treatment of Hyponatraemia Secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion in Sweden." BMC Endocrine Disorders, vol. 16, 2016, p. 1, https://doi.org/10.1186/s12902-016-0104-z.